HRES803-119

In Committee

Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.

119th Congress Introduced Oct 10, 2025

Legislative Progress

In Committee
Introduced Committee Passed
Oct 10, 2025

Mr. Rose (for himself, Mrs. Harshbarger, Mr. Carter of Georgia, …

Summary

Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abo

Model: claude-opus-4
Generated: Jan 8, 2026 18:55

Evidence Chain:

This summary is derived from the structured analysis below. See "Detailed Analysis" for per-title beneficiaries/burden bearers with clause-level evidence links.

Primary Purpose

Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abo

Policy Domains

Government

Legislative Strategy

"Policy"

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology